Design and characterization of diclofenac sodium tablets containing tamarind seed polysaccharide as release retardant

International Journal of PharmTech Research

Volumn 1, Issue 2, 2009, Pages 191-195

  Deveswaran, R ^a   Abraham, Sindhu ^a   Bharath, S ^a   Basavaraj, B V ^a   Furtado, Sharon ^a   Madhavan, V ^a  

^a M S RAMAIAH UNIVERSITY OF APPLIED SCIENCES   (India)

Author keywords

Diclofenac sodium; Polymer matrix tablets; Tamarind seed polysaccharide

Indexed keywords

EID: 77953394821     PISSN: None     EISSN: 09744304     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Bonferoni MC, Rossi S, Tamayo M, Pedraz JL, Dominguez Gil A, Caramella C., On the employment of l-Carrageenan in a matrix system I. Sensitivity to dissolution medium and comparison with Na carboxymethyl cellulose and Xanthan gum, J.Control Release., 1993, 26, 119. (Pubitemid 23226017)
2. Ford JL and Edgar PJ., Importance of drug type, tablet shape and added diluents on drug release kinetics form hydroxy propyl methylcellulose matrix tablets, Int.J.Pharm., 1987, 40, 223.
3. Talukdar MM., Evaluation of Xanthan gum as a hydrophilic matrix for controlled release dosage form preparations, Drug Dev. Ind.Pharm., 1993, 19, 1043.
4. Sujja-areevath J, Munday DL, Cox PJ, Khan KA., Release characteristics of Diclofenac sodium from encapsulated natural gum mini-matrix formulations,Int.J.Pharm., 1996, 139, 53.
5. Sano M, Miyata E, Tamano S, Hagiwara A, Ito N, Shirai T., Lack of carcinogenicity of tamarind seed polysaccharide in B6C3F mice, Food Chem. Toxicol., 1996, 34, 463-467 (Pubitemid 26171976)
6. nd ed., Academic Press, New York, 1973, 369-411.
7. Gidley MJ, Lillford PJ, Rowlands DW., Structural and solution properties of tamarind- seed polysaccharide, Carbohydrate Res., 1991, 214, 299-314.
8. Rao PS, Ghosh TP, Krishna S., Extraction and purification of tamarind seed polysaccharide, J. Sci Ind Res., 1946, 4, 705.
9. United States Pharmacopoeia., USP 27, Asian Edition, United States Pharmacopoeial Covention Inc. at Washington D.C., 2004, 2621.
10. Kulkarni.RV and Shah A., Development and evaluation of xyloglucan matrix tablets containing naproxen, Asian J.Pharm., 2008, 4, 102.